1. Home
  2. MATW vs VIR Comparison

MATW vs VIR Comparison

Compare MATW & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$25.95

Market Cap

827.2M

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$5.88

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
VIR
Founded
1850
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.2M
825.0M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
MATW
VIR
Price
$25.95
$5.88
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$25.73
AVG Volume (30 Days)
283.0K
1.8M
Earning Date
02-05-2026
11-05-2025
Dividend Yield
3.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,497,689,000.00
$16,860,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.77
$46.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.50
$4.16
52 Week High
$32.00
$14.45

Technical Indicators

Market Signals
Indicator
MATW
VIR
Relative Strength Index (RSI) 50.30 45.40
Support Level $25.76 $5.76
Resistance Level $27.06 $6.12
Average True Range (ATR) 0.73 0.32
MACD -0.14 -0.06
Stochastic Oscillator 15.31 11.69

Price Performance

Historical Comparison
MATW
VIR

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: